Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Combination therapy to enhance NK cell mediated cytotoxicity
Apparatus and method for sterilizing vessel with electron beam
System and method for video encoding
Systems and methods for managing and utilizing excess corn residue
Correcting color plate data for mis-registration in a sub-scanning direction by performing a pixel transition at the transition point aligned in the main-scanning direction
Single-lens reflex digital camera which displays an image for live view
Embedded package and method for manufacturing the same
  Randomly Featured Patents
Binder compositions comprising low molecular weight poly(orthomethylolated) phenolic compound and novolac resin
Archival photoprint laminate
Distribution result verification method for information distribution system
Lighting fixture vanity strip
AFP to postscript conversion
Method of making carton space dividers
One-component magnetic toner for use in electrophotography
ESD protection device for high performance IC
Fan impeller with flexible blades
Modular systems and methods for managing data storage operations